Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-002289
Accepted
2023-08-08 00:15:07
Documents
1
Effectiveness Date
2023-08-07
Registration Form
POS AM
Reference AccNo
0001104659-23-087817

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 606
  Complete submission text file 9999999995-23-002289.txt   1709
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-258741 | Film No.: 231149138
SIC: 2834 Pharmaceutical Preparations